A SOLID ORAL PHARMACEUTICAL FORMULATION OF ENZALUTAMIDE

DOP2026000073AUndetermined Publication Date: 2026-06-15BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: DO2026000073
Authority / Receiving Office: DO · DO
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-09-18
Filing Date: 2026-03-18
Publication Date: 2026-06-15

Application Information

Patent Timeline

18 Sep 2024

Priority

18 Mar 2026

Application

DO2026000073

15 Jun 2026

Publication

DOP2026000073A

IPC: A61K31/4166; A61K47/06; A61K47/10; A61K47/30; C07D233/86

CPC: C07D233/86; A61K31/4166; A61K9/2054; A61K9/146; A61K9/2095

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a novel oral solid pharmaceutical formulation of enzalutamide or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable excipients. The present invention provides a pharmaceutical formulation of enzalutamide comprising one or more pharmaceutically acceptable polymers. Furthermore, the present invention also provides an improved process for preparing the oral solid pharmaceutical formulation of enzalutamide.

Need to check novelty before this filing date? Find Prior Art